|
Trasplante cardiaco: Artículos interesantes |
|
|
Eghtesady P, Almond CS, Tjossem C, Epstein D, Imamura M, Turrentine M, Tweddell J, Jaquiss RD, Canter C; Berlin Heart Investigators. Post-transplant Outcomes of Children Bridged to Transplant With the Berlin Heart EXCOR Pediatric Ventricular Assist Device. Circulation 2013 Sep 10; 128 (26 Suppl 1): S24-31. |
|
|
González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, López-Granados A, Escribano P, Farrero M. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant 2013 Sep 12. |
|
|
Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. J Heart Lung Transplant 2013 Aug 29. doi:pii: S1053-2498(13)01376-4. 10.1016/j.healun.2013.08.002. [Epub ahead of print] |
|
|
Jaramillo N, Segovia J, Gómez-Bueno M, García-Cosío D, Castedo E, Serrano S, Burgos R, García Montero C, Ugarte J, Martínez Cabeza P, Alonso-Pulpón L. Characteristics of Patients With Survival Longer Than 20 Years Following Heart Transplantation. Rev Esp Cardiol 2013 Aug 6. |
|
|
Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, González-Vilchez F, Villa-Arranz A, Delgado-Jiménez J, Lage-Galle E, Pérez-Villa F, Lambert-Rodríguez JL, Manito-Lorite N, Arizon-Del Prado JM, Brossa-Loidi V, Pascual-Figal D, Fuente-Galán L de L, Sanz-Julve M, Muñiz-García J, Crespo-Leiro M. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail 2013 Jul;6(4):763-72. |
|
|
Melero-Ferrer JL, Sánchez-Lázaro IJ, Almenar-Bonet L, Martínez-Dolz L, Buendía-Fuentes F, Portolés-Sanz M, Rivera-Otero M, Salvador-Sanz A. Impact of basal heart rate on long-term prognosis of heart transplant patients. Transpl Int 2013 May; 26 (5): 502-7. |
|
|
Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant 2013 May; 13 (5): 1203-16. |
|
|
Bhama JK, Shulman J, Bermudez CA, Bansal A, Ramani R, Teuteberg JJ, Shullo M, McNamara DM, Kormos RL, Toyoda Y. Heart transplantation for adults with congenital heart disease: results in the modern era. J Heart Lung Transplant 2013 May; 32 |
|
|
Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant 2013 May; 32 (5): 492-8. |
|
|
Zuckermann A, Wang SS, Epailly E, Barten MJ, Sigurdardottir V, Segovia J, Varnous S, Turazza FM, Potena L, Lehmkuhl HB. Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now? Transplant Rev (Orlando) 2013 May. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|